⌘K
Loading ticker…
Krystal Biotech, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Krystal Biotech, Inc. Common Stock (KRYS) has a 3-month relative strength percentile of 89 and a leadership percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 76. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.0%, relative volume 3.92×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 89, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
KRYS is in a stage 2 uptrend, week 8. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 22.9% / 49.3%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
KRYS is held by 9 ETFs as of Mar 2026. Top owner: IJR at 0.44% weight, $400M notional. Top 3 carry $772M.
Top 9 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.44% | $400M |
| VTIVanguard Total Stock Market ETF | 0.01% | $215M |
| VBVanguard Small Cap ETF | 0.10% | $157M |
| IWMiShares Russell 2000 ETF | 0.22% | $156M |
| VBKVanguard Small-Cap Growth ETF | 0.23% | $88M |
| XBIState Street SPDR S&P Biotech ETF | 1.15% | $86M |
| VXFVanguard Extended Market ETF | 0.09% | $74M |
| IWOiShares Russell 2000 Growth ETF | 0.43% | $52M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $8M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KRYS Jan avg: 2.46% median: 3.45% win: 75% σ: 9.77% n: 4 2022-04-12 → 2026-05-29 | KRYS Feb avg: 13.20% median: 5.46% win: 50% σ: 21.09% n: 4 2022-04-12 → 2026-05-29 | KRYS Mar avg: 0.91% median: -0.84% win: 50% σ: 7.65% n: 4 2022-04-12 → 2026-05-29 | KRYS Apr avg: -4.77% median: -5.78% win: 40% σ: 7.95% n: 5 2022-04-12 → 2026-05-29 | KRYS May avg: 6.79% median: 4.53% win: 60% σ: 24.54% n: 5 2022-04-12 → 2026-05-29 | KRYS Jun avg: 8.75% median: 10.32% win: 75% σ: 6.51% n: 4 2022-04-12 → 2026-05-29 (current) | KRYS Jul avg: 11.49% median: 11.24% win: 100% σ: 1.58% n: 4 2022-04-12 → 2026-05-29 | KRYS Aug avg: -4.35% median: -3.79% win: 0% σ: 1.39% n: 4 2022-04-12 → 2026-05-29 | KRYS Sep avg: 1.35% median: -3.65% win: 25% σ: 12.46% n: 4 2022-04-12 → 2026-05-29 | KRYS Oct avg: 4.29% median: 5.25% win: 75% σ: 7.97% n: 4 2022-04-12 → 2026-05-29 | KRYS Nov avg: 3.90% median: 6.00% win: 75% σ: 11.17% n: 4 2022-04-12 → 2026-05-29 | KRYS Dec avg: 3.34% median: 7.50% win: 75% σ: 17.50% n: 4 2022-04-12 → 2026-05-29 |